Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Perry

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Journal of the Neurological Sciences|October 1, 1989
Dominantly inherited olivopontocerebellar atrophy from eastern Cuba. Clinical, neuropathological, and biochemical findingsG Orozco, R Estrada, T L Perry, et al.
European Journal of Clinical Nutrition|November 22, 1997
Lifestyle intervention in people with insulin-dependent diabetes mellitus (IDDM)T L Perry, J I Mann, N J Lewis-Barned, et al.
Journal of the Neurological Sciences|November 1, 1987
Alpha-tocopherol and beta-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridineT L Perry, V W Yong, S Hansen, et al.
Annals of Neurology|October 1, 1985
Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidusT L Perry, M G Norman, V W Yong, et al.
Blood Pressure Monitoring|August 24, 2001
Validation of a new algorithm for the BPM-100 electronic oscillometric office blood pressure monitorJ M Wright, G S Mattu, T L Perry, et al.
Annals of Neurology|December 1, 1979
Familial fatal Parkinsonism with alveolar hypoventilation and mental depressionA Purdy, A Hahn, H J Barnett, et al.
Neuroscience Letters|September 30, 1985
Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouseT L Perry, V W Yong, R M Clavier, et al.
Neuroscience Letters|August 5, 1985
Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouseT L Perry, V W Yong, K Jones, et al.
Journal of Neurochemistry|October 1, 1984
Nigrostriatal dopaminergic neurons remain undamaged in rats given high doses of L-DOPA and carbidopa chronicallyT L Perry, V W Yong, M Ito, et al.
Neurology|April 1, 1982
A double-blind clinical trial of isoniazid in Huntington diseaseT L Perry, J M Wright, S Hansen, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Journal of the Neurological Sciences|October 1, 1989
Dominantly inherited olivopontocerebellar atrophy from eastern Cuba. Clinical, neuropathological, and biochemical findingsG Orozco, R Estrada, T L Perry, et al.
European Journal of Clinical Nutrition|November 22, 1997
Lifestyle intervention in people with insulin-dependent diabetes mellitus (IDDM)T L Perry, J I Mann, N J Lewis-Barned, et al.
Journal of the Neurological Sciences|November 1, 1987
Alpha-tocopherol and beta-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridineT L Perry, V W Yong, S Hansen, et al.
Annals of Neurology|October 1, 1985
Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidusT L Perry, M G Norman, V W Yong, et al.
Blood Pressure Monitoring|August 24, 2001
Validation of a new algorithm for the BPM-100 electronic oscillometric office blood pressure monitorJ M Wright, G S Mattu, T L Perry, et al.
Annals of Neurology|December 1, 1979
Familial fatal Parkinsonism with alveolar hypoventilation and mental depressionA Purdy, A Hahn, H J Barnett, et al.
Neuroscience Letters|September 30, 1985
Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouseT L Perry, V W Yong, R M Clavier, et al.
Neuroscience Letters|August 5, 1985
Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouseT L Perry, V W Yong, K Jones, et al.
Journal of Neurochemistry|October 1, 1984
Nigrostriatal dopaminergic neurons remain undamaged in rats given high doses of L-DOPA and carbidopa chronicallyT L Perry, V W Yong, M Ito, et al.
Neurology|April 1, 1982
A double-blind clinical trial of isoniazid in Huntington diseaseT L Perry, J M Wright, S Hansen, et al.
Pageof 15